Trending...
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
- Heritage at Manalapan Welcomes New Sales Team as Luxury Single-Family Home Community Continues to Grow
FAYETTEVILLE, Ark. - ncarol.com -- Lineus Medical announces a significant reduction in price of nearly 15% for its flagship product, SafeBreak Vascular, in the United States. After creating a new device classification with the FDA and becoming the first break-away device available for IV lines in the US, SafeBreak Vascular was first released with a list price of $6.90. Since its release, increased sales volume and concentrated efforts toward manufacturing efficiencies support a price adjustment with a new list price of $5.90, effective on September 1st, 2024.
SafeBreak Vascular is the only break-away device for IV lines proven to reduce IV complications1. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.
More on ncarol.com
"A large focus of our strategy is maximizing our economic value proposition for the hospital." Lineus Medical's Vice President of Sales, Larry Hayes comments, "Reducing our price allows for both current and new accounts to take advantage of cost savings, and in doing so, we are making it easier for hospitals to invest in improved vascular access care for their patients."
Vance Clement, CEO of Lineus Medical, stated, "Inflation is hitting everyone, and we are all used to prices going up. This is especially true in healthcare, where prices never go down. However, SafeBreak, which is proudly made in the USA, is changing that. As we continue to grow, we will keep investing in manufacturing so that we can lower the cost of SafeBreak again in the future."
Lineus Medical is committed to improving patient safety and advancing vascular access care and believes that this price reduction is another important step in our mission to remove the pains associated with medical lines. Anyone interested in SafeBreak Vascular's price reduction can visit our website www.lineusmed.com to learn more.
About Lineus Medical
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn.
SafeBreak Vascular is the only break-away device for IV lines proven to reduce IV complications1. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.
More on ncarol.com
- FBI/DoW plot uncovered to hurt Trump/Vance through encouraged "widespread" cybersecurity breaches and racketeering theft of $80m in USDA payments
- Bettingbladet releases H1 2026 report on the Swedish online gambling market
- Garage door installation or repair in Minnesota? Which makes more sense for your family?
- Super Rooter Expands to 190 Plumbing, Sewer, and Drain Service Locations Across the United States
- Google AI Says KayeDinero Isn't the Greatest Female Producer. She Asks: Who Decides?
"A large focus of our strategy is maximizing our economic value proposition for the hospital." Lineus Medical's Vice President of Sales, Larry Hayes comments, "Reducing our price allows for both current and new accounts to take advantage of cost savings, and in doing so, we are making it easier for hospitals to invest in improved vascular access care for their patients."
Vance Clement, CEO of Lineus Medical, stated, "Inflation is hitting everyone, and we are all used to prices going up. This is especially true in healthcare, where prices never go down. However, SafeBreak, which is proudly made in the USA, is changing that. As we continue to grow, we will keep investing in manufacturing so that we can lower the cost of SafeBreak again in the future."
Lineus Medical is committed to improving patient safety and advancing vascular access care and believes that this price reduction is another important step in our mission to remove the pains associated with medical lines. Anyone interested in SafeBreak Vascular's price reduction can visit our website www.lineusmed.com to learn more.
About Lineus Medical
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn.
Source: Lineus Medical
Filed Under: Health
0 Comments
Latest on ncarol.com
- Congressman Chuck Edwards (NC-11) Presents ReadyCommunities Partnership 2026 National Service Award to Local Businessman / US Air Force Veteran
- Cress Creeks Farm Opens Fall Corn Maze and Baby Lamb Hayride Experience in Ellijay, Georgia
- Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators
- Pipeline Developer Isn't Just a Song: KayeDinero Builds Software, Markets and Music
- Who Is KayeDinero? The Asheville Artist Also Builds Software and Trading Systems
- Leaping Cat Creative Takes Shape Around the Problems Nobody Quite Owns
- White Coat Financial Partners Announces Launch of Next Generation Practice Optimization Software
- Kerri Lawless Introduces New Home-Selling Option for Local Homeowners
- As Boone Takes Art to the Streets, KayeDinero Asks What Makes Creativity Human
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
- Black Mountain Meets "Human Error": KayeDinero on What Technology Can't Reproduce
- As Brevard Heads Into Mountain Song Weekend, KayeDinero Brings a Different Kind of WNC Sound
- Why Did KayeDinero Put Haywood Road Into a Song?
- Shelter Structures America makes European debut at TEMPOR EXPO 2026 in Fulda, Germany
- TekTone innovation meets patient care
- HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
- Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
- OneVizion Launches Vera AI, Bringing Connected Operational Context to Infrastructure Teams
- P-Wave Press Announces Pushing the Wave 2025 by L.A. Davenport

